RecruitingNot ApplicableNCT06316557
HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke
Sponsor
Zi-Xiao Li
Enrollment
70 participants
Start Date
Jan 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment. Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site, once daily for a total of five days.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- (1)ischemic stroke, with an initial incident occurring within 2 weeks;(2)MoCA<26;
Exclusion Criteria1
- (1)Cerebral hemorrhage or subarachnoid hemorrhage;(2)A pre-existing history of epilepsy;
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEiTBS group
iTBS on the contralesional cerebellum, twice a day for seven days
DEVICEcontrol group
shame stimulation on the contralesional cerebellum, twice a day for seven days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06316557
Related Trials
Cerebrospinal Fluid Mitochondrial Biomarkers in Ischemic Stroke and Alzheimer Disease
NCT076009961 location
Goal Attainment Scaling in Upper Limb Spasticity Treatment
NCT049756461 location
Proprioceptive Error Correction for Post-Stroke Upper Limb Rehabilitation
NCT071569551 location
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
NCT055183051 location
Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial
NCT0711155928 locations